Breast conserving therapy shows survival benefit compared to mastectomy in early-stage patients with hormone receptor positive disease
When factoring in what is now known about breast cancer biology and
heterogeneity, breast conserving therapy (BCT) may offer a greater
survival benefit over mastectomy to women with early stage,
hormone-receptor positive disease, according to research from The University of Texas MD Anderson Cancer Center.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: Biology | Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Hormones | Mastectomy | Texas University | Women